argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
891.32
+49.05 (5.82%)
At close: Jun 5, 2026, 4:00 PM EDT
889.00
-2.32 (-0.26%)
After-hours: Jun 5, 2026, 7:52 PM EDT
argenx SE Employees
argenx SE had 1,863 employees as of December 31, 2025. The number of employees increased by 264 or 16.51% compared to the previous year.
Employees
1,863
Change (1Y)
264
Growth (1Y)
16.51%
Revenue / Employee
2.55M LKR
Profits / Employee
799.27K LKR
Market Cap
55.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,863 | 264 | 16.51% |
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 148 | 78.72% |
| Dec 31, 2019 | 188 | 83 | 79.05% |
| Dec 31, 2018 | 105 | 32 | 43.84% |
| Dec 31, 2017 | 73 | 15 | 25.86% |
| Dec 31, 2016 | 58 | 17 | 41.46% |
| Dec 31, 2015 | 41 | 9 | 28.13% |
| Dec 31, 2014 | 32 | 10 | 45.45% |
| Dec 31, 2013 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
ARGX News
- 2 days ago - argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference - MarketBeat
- 3 days ago - ARGX Reiterated by Wedbush -- Maintains Price Target at $1000 - GuruFocus
- 4 days ago - argenx SE Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 4 days ago - ArgenX Reports Phase 2 Extension Results For Efgartigimod In Treating Autoimmune Diseases - Nasdaq
- 4 days ago - Argenx (ARGX) Presents New Vyvgart Data at EULAR 2026 Congress - GuruFocus
- 4 days ago - Argenx presents new Vyvgart data at EULAR - TheFly
- 5 days ago - argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren's Disease at EULAR 2026 - GlobeNewsWire
- 6 days ago - ARGX Maintained by Wells Fargo -- Price Target Raised to $1291 - GuruFocus